EQS-CMS

    109 Aufrufe 109 0 Kommentare 0 Kommentare

    Siemens Healthineers AG: Release of a capital market information

    Für Sie zusammengefasst
    • Siemens Healthineers AG bought back 100,000 shares.
    • Total buyback volume since March 2025: 3,300,885 shares.
    • Transactions executed on Frankfurt Stock Exchange (XETRA).
    EQS-CMS - Siemens Healthineers AG: Release of a capital market information

    EQS Post-admission Duties announcement: Siemens Healthineers AG / Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 2024/2809 (MAR) in conjunction with Art. 2 para. 2, para. 3 of the Delegated Regulation (EU) No. 2016/1052 Share buyback 8th
    Siemens Healthineers AG: Release of a capital market information

    19.05.2025 / 18:00 CET/CEST
    Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group.
    The issuer is solely responsible for the content of this announcement.


    Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 2024/2809 (MAR) in conjunction with Art. 2 para. 2, para. 3 of the Delegated Regulation (EU) No. 2016/1052

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Siemens Healthineers!
    Long
    42,80€
    Basispreis
    0,32
    Ask
    × 14,22
    Hebel
    Zum Produkt
    Blatt
    Short
    48,65€
    Basispreis
    0,32
    Ask
    × 14,22
    Hebel
    Zum Produkt
    Blatt
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Share buyback 8th Interim Reporting

    In the time period from and including 12 May 2025 until and including 18 May 2025, a number of 100,000 shares of Siemens Healthineers AG were bought back within the framework of the share buyback of Siemens Healthineers AG; on 19 March 2025, Siemens Healthineers AG disclosed pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 2024/2809 (MAR) in conjunction with Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052 the start of the share buyback on 24 March 2025.

    Shares were bought back as follows:

    Day of purchase Aggregated volume of shares Weighted average price (EUR)1
    05/12/2025 20,000 48.7753
    05/13/2025 20,000 49.1607
    05/14/2025 20,000 48.6388
    05/15/2025 20,000 48.4019
    05/16/2025 20,000 49.4288

     

    The transactions are published in a detailed form on the website of Siemens Healthineers AG (https://www.siemens-healthineers.com/investor-relations/share).

    The total volume of shares which were bought back within the framework of the share buyback in the time period from and including 24 March 2025 until and including 18 May 2025 amounts to 3,300,885 shares.

    The purchase of the shares of Siemens Healthineers AG is carried out by a credit institution that has been commissioned by Siemens Healthineers AG; the shares are repurchased exclusively on the electronic trading platform of the Frankfurt Stock Exchange (XETRA).

    Munich, 19 May 2025

    Siemens Healthineers AG

    The Managing Board

    ______________________________

    1Excluding incidental acquisition costs, rounded to four decimal places according to commercial practice.



    19.05.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com


    Language: English
    Company: Siemens Healthineers AG
    Siemensstr. 3
    91301 Forchheim
    Germany
    Internet: https://www.siemens-healthineers.com

     
    End of News EQS News Service

    2140734  19.05.2025 CET/CEST

    Siemens Healthineers

    -1,85 %
    -1,46 %
    -6,15 %
    -12,31 %
    -16,09 %
    -11,71 %
    +9,36 %
    +48,03 %
    ISIN:DE000SHL1006WKN:SHL100




    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-CMS Siemens Healthineers AG: Release of a capital market information EQS Post-admission Duties announcement: Siemens Healthineers AG / Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 2024/2809 (MAR) in conjunction with Art. 2 para. 2, …